The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for elasomeran (Moderna Australia Pty Ltd)
Active ingredients
elasomeran
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Indication
For active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 12 years of age and older
Therapeutic area
Infectious diseases